Ascensis Pharma Says FDA Will Review Application for Adult Treatment of Growth Hormone Deficiency

Ascensis Pharma表示，美國食品和藥品管理局將審查成人生長激素缺乏症治療的申請

WSJ · 12/13 06:21

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.